This study examines the impact of guided breathing exercises on stress and heart rate variability (HRV) in autistic young adults. It explores how daily movement behavior (sleep, physical activity and sedentary behavior) influences HRV and to what extent two guided breathing exercises can affect HRV. Additionally, the study investigates how participants perceive the exercises in terms of usability and usefulness.
For many autistic individuals, transitioning into adulthood can be challenging and stressful. This stress often affects their mental health. The autistic community has highlighted the need for better mental health support, including accessible and effective ways to manage stress. Among the non-pharmacological interventions aimed at improving mental health via stress reduction, guided breathing interventions are promising, also on a psychophysiological level. During a stressful situation, internal regulatory processes take place to maintain balance, starting by activating the autonomic nervous system (ANS). Prior work indicates that a dysfunction of the ANS contributes to the heightened mental health challenges observed in autistic individuals. Heart rate variability (HRV), the variation in time between heartbeats, is an physiological index of the functioning of the ANS. The Neurovisceral Integration Theory highlights the role of parasympathetic regulation of the heart rate, associating higher vagally mediated HRV with better health, emotional regulation and executive functioning.In autistic individuals, the overall levels of cardiac vagal modulation are lower compared to neurotypical peers. To date, research investigating the potential of interventions aimed at increasing HRV in autistic individuals is scarce. Moreover, HRV is influenced by several aspects (e.g., sleep, physical activity) and knowledge on their combined impact is necessary to understand how HRV can be used in research and clinical practice. Therefore, in this project, the investigators will explore the role of physical activity, sedentary behavior, and sleep on HRV and determine what constitutes a significant change in HRV. The investigators will also examine the psychophysiological effects, feasibility, and acceptability of the two leading protocols in guided breathing interventions (heart rate variability biofeedback and slow-paced breathing). HRV-BF optimizes HRV by guiding individuals to breathe at their resonance frequency, synchronizing heart rate and breathing. SPB prescribes to breathe at a fixed pace of 6 breaths per minute.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
68
Guided breathing exercises are performed at a fixed pace of 6 breaths per minute (SPB) .
Guided breathing exercises are performed at each participant's individually determined resonance frequency, which typically falls between 4.5 and 7 breaths per minute (HRV-BF).
KU Leuven
Leuven, Vlaams Brabant, Belgium
RECRUITINGUPC Z.Org
Leuven, Belgium
NOT_YET_RECRUITINGChange in cardiac vagal modulation of heart rate based on resting-state HRV.
Calculated as (1) a time domain measure (RMSSD: Root Mean Square of Successive Differences). Three-lead electrocardiographic data will be captured using the NeXus-10 MKII biofeedback device and Biotrace+ Software (MindMedia B.V., The Netherlands). Disposable, self-adhesive and pre-gelled electrodes (Kendall™ ECG Electrodes Arbo™ H124SG, Covidien, Ireland) will be used without specific skin preparations at a sampling rate of 256 SPS. For the recording of the breathing frequency, an elastic band with stretch-sensitive sensors and a sampling rate of 32 SPS is placed around the waist.
Time frame: At all assessment points: at the start of the study (week 0, time point 0) before the intervention (week 5, time point 1) + after 5 weeks of intervention (week 10, time point 2) + after 5 weeks at the follow-up (week 15, time point 3)
Change in cardiac vagal modulation of heart rate based on resting-state HRV
Calculated as (2) a frequency domain measures (HF-HRV). Three-lead electrocardiographic data will be captured using the NeXus-10 MKII biofeedback device and Biotrace+ Software (MindMedia B.V., The Netherlands). Disposable, self-adhesive and pre-gelled electrodes (Kendall™ ECG Electrodes Arbo™ H124SG, Covidien, Ireland) will be used without specific skin preparations at a sampling rate of 256 SPS. For the recording of the breathing frequency, an elastic band with stretch-sensitive sensors and a sampling rate of 32 SPS is placed around the waist.
Time frame: At all assessment points: at the start of the study (week 0, time point 0) before the intervention (week 5, time point 1) + after 5 weeks of intervention (week 10, time point 2) + after 5 weeks at the follow-up (week 15, time point 3)
Change in mental health indicators
(1) Symptom Checklist-90 Revised (SCL-90-R): The Dutch version measures eight dimensions: anxiety (ANG), agoraphobia (AGO), depression (DEP), somatization (SOM), cognitive-performance deficits (IN), interpersonal sensitivity and mistrust (SEN), hostility (HOS), and sleep difficulties (SLA). Each item is rated on a 5-point Likert scale from 1 ("not at all") to 5 ("extremely"). The total score ranges from 90 to 450. The total score provides a general measure of psychological distress. Higher scores indicate more symptoms and distress. The scores on the eight dimensions range for ANG between 10 and 50, for AGO between 7 and 35, for DEP between 16 and 80, for SOM between 12 and 60, for IN between 9 and 45, for SEN between 18 and 90, for HOS between 6 and 30 and for SLA between 3 and 15. Higher scores indicate more symptoms and distress.
Time frame: At all assessment points: at the start of the study (week 0, time point 0) before the intervention (week 5, time point 1) + after 5 weeks of intervention (week 10, time point 2) + after 5 weeks at the follow-up (week 15, time point 3)
Change in mental health indicators
(2) Depression Anxiety Stress Scales (DASS-21): The Dutch version of the DASS-21 measures the presence of symptoms of depression, anxiety, and stress. In consists of 21 items and takes about 10 minutes to complete. Each item is rated on a 4-point Likert scale from 0 ("did not apply to me at all") to 3 ("applied to me very much, or most of the time"). The scale yields three subscale scores: Depression, Anxiety, and Stress, each based on 7 items. Subscale scores therefore range from 0 to 21. To calculate the scores, the subscale scores are multiplied by two, resulting in a final range of 0 to 42 per subscale. Higher scores indicate greater symptom severity.
Time frame: At all assessment points: at the start of the study (week 0, time point 0) before the intervention (week 5, time point 1) + after 5 weeks of intervention (week 10, time point 2) + after 5 weeks at the follow-up (week 15, time point 3)
Change in mental health indicators
(3) Perceived stress scale (PSS-10): The Dutch version of the PSS measures the degree to which situations in one's life are appraised as stressful, that is, how unpredictable, uncontrollable, and overloaded respondents experience their lives. It consists of 10 items and takes maximum 5 minutes to complete. Each item is rated on a 5-point Likert scale ranging from 0 ("never") to 4 ("very often"). Four items are positively stated and are reverse-scored (item 4,5,7 en 8). Total scores range from 0 to 40, with higher scores indicating higher levels of perceived stress
Time frame: At all assessment points: at the start of the study (week 0, time point 0) before the intervention (week 5, time point 1) + after 5 weeks of intervention (week 10, time point 2) + after 5 weeks at the follow-up (week 15, time point 3)
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their usability. This aspect will be assessed through a self-report questionnaire, including the registration of perceived stress before and after each sessions, using a Visual Analogue Scale (VAS) ranging from "none" to "a lot".
Time frame: For 5 weeks 4 times per day (before and after each sessions) during the intervention phase (between week 5 and week 10)
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their acceptability. This aspect will be assessed through a self-report questionnaire, including the registration of the overall experience of each session, using a Visual Analogue Scale (VAS) after each session going form "very unpleasant" to "very pleasant".
Time frame: For 5 weeks 4 times per day during the intervention phase (between week 5 and week 10)
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their, safety. This aspect will be assessed though self-report questionnaires, including the registration of adverse events and mild negative reactions.
Time frame: During the intervention phase (between week 5 and week 10) and during the once per week guided intervention sessions at week 5, 6 and 7.
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their, safety. This aspect will be assessed though through observations and contact with the investigator during the guided intervention sessions
Time frame: During the guided intervention sessions at week 5, 6 and 7.
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their, safety. This aspect will be assessed though the registration of adverse events and mild negative reactions.
Time frame: During the intervention phase (between week 5 and week 10) and during the once per week guided intervention sessions at week 5, 6 and 7.
feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their acceptability, safety, usability and adaptability to daily life. These aspects will be assessed through in-depth interviews. The interview guide was developed based on the Theoretical Framework of Acceptability (TFA). This framework allows for a comprehensive exploration of intervention acceptability through seven key constructs (affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy).
Time frame: At time point 3 (week 15) during the follow-up assessment
Feasibility and acceptability of the HRV-BF and SPB interventions.
The investigators will explore how participants experience the guided breathing protocols, including their usability. This aspect will be assessed through a self-report questionnaire, namely: the System Usability Scale (SUS), which will provide insight into the usability of the digitally delivered home-based training. Each item will be scored on a five-point Likert scale ranging from "strongly disagree" to "strongly agree. The item scores are summed to calculate the total SUS score, which ranges from 0 to 100, representing the overall system usability. Overall scores from 0 to 50 indicate "not acceptable," 51 to 70 indicate marginal level of usability, and 71 to 100 indicate "acceptable" levels of usability.
Time frame: At time point 3 (week 15) during the follow-up assessment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.